Medtech Insight
>>Device Area

Newer Data Fades Paclitaxel Risk, Physician Group Says

11 Sep 2019

A meta-analysis that seemed to show an increased mortality risk tied to paclitaxel-coated balloons and stents sent shockwaves through the device industry last year. But a more complete data review funded by nonprofit group VIVA Physicians may show that the issue has been overestimated.

Paclitaxel-coated balloons and stents may pose less of a mortality risk than earlier studies indicated, a member of the board of directors of physician group VIVA told Medtech Insight.

A study published in the Journal of the American Heart Association (JAHA) in December 2018 found that peripheral arterial...